MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest Issue
A new set of objective and simple phenotyping tests that categorize patients by four distinct subtypes of obesity is set to disrupt obesity care, by enabling the tailoring of therapy to a patient's syndrome to create care that is more successful and cost-effective. MedTech Strategist interviews the Mayo Clinic’s Andres Acosta, a co-founder of Phenomix Sciences, which is commercializing the tests.
As advances in gene and cell therapies make the possibility of curing some inherited genetic diseases a reality, the need for rapid screening and diagnosis of genetic variants is getting more urgent. Immunologist and cell therapy expert Stephen Kingsmore is at the forefront of making that happen.
2C Tech was founded by two ophthalmologists at the University of Colorado who created a new device therapy that harnesses trillions of quantum dots injected into the back of the eye to restore neural pathways lost in the course of retinal diseases such as retinitis pigmentosa. While the therapy is a device, it is delivered like a drug, and will have gross margins that look a lot more like a pharmaceutical than a device.